“…All isolates were determined to be resistant against multiple antibiotics (at least six antibioticresistant). The prevalence of antibiotic resistance of ESBL-positive E. coli isolates to ampicillin, amoxicillin/ clavulanic acid, cefotaxime, ceftazidime, aztreonam, gentamicin, amikacin, tobramycin, streptomycin, nalidixic acid, ciprofloxacin, trimethoprim/sulfamethoxazole, tetracycline, and chloramphenicol was 100% (n = 25), 56% (14), 5% (13), 80% (20), 40% (10), 76% (19), 4% (1), 56% (14), 96% (24), 92% (23), 48% (12), 88% (22), 80% (20), and 80% (20), respectively. All of the ESBL E. coli isolates were susceptible to cefoxitin and imipenem.…”